Mix it Up: Pharmacy Podcast

Episode 2.11 - Preventing Adverse Drug Events: The Study of Pharmacovigilance, Interview with Sara Rogers PharmD.

March 09, 2021 Innovation Compounding Season 2 Episode 11
Mix it Up: Pharmacy Podcast
Episode 2.11 - Preventing Adverse Drug Events: The Study of Pharmacovigilance, Interview with Sara Rogers PharmD.
Show Notes

The World Health Organisation has defined pharmacovigilance as "The science and activities relating to the detection, assessment, understanding, and prevention of adverse effects or any other possible drug-related problem."

In this episode, we're discussing adverse drug event prevention and the study of pharmacovigilance with pharmacist and researcher Dr. Sara Rogers, PharmD, BCPS. 

Listen along as we review:

  • The current state of drug safety in the U.S. 
  • The study of pharmacovigilance
  • Prevention of adverse drug events
  • The American Society of Pharmacovigilance (ASP)
  • Pharmacogenomics
  • And more...


Guest Speaker Bio
Sara Rogers, PharmD, BCPS, is a Board Certified Pharmacotherapy Specialist (BCPT), researcher and nonprofit director. As a proponent of personalized medicine and preventing harm from medication use, she co-founded the American Society of Pharmacovigilance in 2018. Since there is a strong genetic component in the way that patients respond to medications, she has taken an active role in addressing barriers to widespread implementation of pharmacogenomics.

Dr. Rogers is a member of the Clinical Pharmacogenetics Implementation Consortium, Chairman of the Pharmacogenomics Access and Reimbursement Coalition, and an organizational member of the NIH National Human Genomics Research Institute (NHGRI) Inter-Society Coordinating Committee. She hopes these efforts will lead to improved health outcomes for patients across the US, regardless of socioeconomic status.

Additional Resources & Links
The American Society of Pharmacovigilance


Follow us on Social Media
LinkedIn
Facebook
Instagram

About Innovation Compounding

Innovation Compounding is licensed as a 503A, compounding pharmacy, accredited by The Pharmacy Compounding Accreditation Board (PCAB®).

Today, we support over 7,000 prescribers, 70,000+ patients, and annually provide 100,000+ prescriptions to 46 states across the U.S. 

We commit to individualized pharmaceutical care by being relentless in our drive for personalized medicine, compassionate toward our patients and doctors, and being a #WellnessAdvocate for our patients’ lives and state of well being.

Learn more about the work we do and how we can help to build your practice by visiting us online:

Innovation Compounding Website

Support the show (https://www.paypal.com/biz/fund?id=EBS8AD46RVKRW)